Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
出版年份 2011 全文链接
标题
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 10, Issue 4, Pages 471-486
出版商
Informa UK Limited
发表日期
2011-04-20
DOI
10.1586/erv.11.29
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans
- (2014) Kenneth Von Eschen et al. Human vaccines & immunotherapeutics
- An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers
- (2011) Eva Van Braeckel et al. CLINICAL INFECTIOUS DISEASES
- Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine
- (2011) Tino F. Schwarz et al. Human vaccines & immunotherapeutics
- Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists
- (2010) Matthew Black et al. Expert Review of Vaccines
- Letter from the Editor
- (2010) Ronald W. Ellis et al. Human vaccines & immunotherapeutics
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine
- (2010) Michel Deschuyteneer et al. Human vaccines & immunotherapeutics
- Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults
- (2010) Jiří Beran et al. Human vaccines & immunotherapeutics
- From the circumsporozoite protein to the RTS,S/AS candidate vaccine
- (2010) Joe Cohen et al. Human vaccines & immunotherapeutics
- From Vaccines to Memory and Back
- (2010) Federica Sallusto et al. IMMUNITY
- Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
- (2010) M. Juliana McElrath et al. IMMUNITY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Immunogenicity, Reactogenicity, and Safety of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women
- (2010) Ryo Konno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Efficacy of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years
- (2010) Ryo Konno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Efficacy of Human Papillomavirus Type 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years
- (2010) Ryo Konno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls
- (2010) Doris M. Rivera Medina et al. JOURNAL OF ADOLESCENT HEALTH
- Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis–inactivated Poliovirus Vaccine to Girls and Young Women
- (2010) José Garcia-Sicilia et al. JOURNAL OF ADOLESCENT HEALTH
- Vaccination with a Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Cervical Cancer Vaccine in Korean Girls Aged 10-14 Years
- (2010) Young-Jae Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women
- (2010) Neerja Bhatla et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- New vaccines for tuberculosis
- (2010) Stefan HE Kaufmann et al. LANCET
- Immunology and the elusive AIDS vaccine
- (2010) Herbert W. Virgin et al. NATURE
- Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
- (2010) Mahamadou A. Thera et al. PLoS One
- The Population Dynamics and Control of Tuberculosis
- (2010) C. Dye et al. SCIENCE
- Tuberculosis: What We Don't Know Can, and Does, Hurt Us
- (2010) D. G. Russell et al. SCIENCE
- Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
- (2010) N. De Carvalho et al. VACCINE
- Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers
- (2010) Jaap T. van Dissel et al. VACCINE
- Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
- (2010) Isabel Leroux-Roels et al. VACCINE
- Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
- (2009) Tino F. Schwarz ADVANCES IN THERAPY
- Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers
- (2009) Olivier Lambotte et al. AIDS
- Human B cell memory
- (2009) Antonio Lanzavecchia et al. CURRENT OPINION IN IMMUNOLOGY
- New concepts in herpes simplex virus vaccine development: notes from the battlefield
- (2009) Gargi Dasgupta et al. Expert Review of Vaccines
- Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆
- (2009) Marie-Pierre David et al. GYNECOLOGIC ONCOLOGY
- The ABC of clinical and experimental adjuvants—A brief overview
- (2009) Richard Brunner et al. IMMUNOLOGY LETTERS
- Plasmodium falciparum-Specific Cellular Immune Responses after Immunization with the RTS,S/AS02D Candidate Malaria Vaccine in Infants Living in an Area of High Endemicity in Mozambique
- (2009) A. Barbosa et al. INFECTION AND IMMUNITY
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Long‐Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children
- (2009) Jahit Sacarlal et al. JOURNAL OF INFECTIOUS DISEASES
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
- (2009) Kent E. Kester et al. JOURNAL OF INFECTIOUS DISEASES
- Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02V-adjuvanted hepatitis B vaccine
- (2009) Murielle Surquin et al. KIDNEY INTERNATIONAL
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer
- (2009) Catherine Gérard et al. Molecular Oncology
- Maternal and Neonatal Herpes Simplex Virus Infections
- (2009) Lawrence Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
- (2009) Bernhards R. Ogutu et al. PLoS One
- Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
- (2009) Michele D. Spring et al. PLoS One
- Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
- (2009) Caterina Guinovart et al. PLoS One
- Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
- (2009) Mark E. Polhemus et al. PLoS One
- Impact of RTS,S/AS02A and RTS,S/AS01B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
- (2009) John N. Waitumbi et al. PLoS One
- A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
- (2009) Bertrand Lell et al. PLoS One
- The Synthetic Plasmodium falciparum Circumsporozoite Peptide PfCS102 as a Malaria Vaccine Candidate: A Randomized Controlled Phase I Trial
- (2009) Régine Audran et al. PLoS One
- Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
- (2009) Seth Owusu-Agyei et al. PLoS One
- Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys
- (2009) S. G. Reed et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys
- (2009) S. Pichyangkul et al. VACCINE
- Development of the RTS,S/AS malaria candidate vaccine
- (2009) Johan Vekemans et al. VACCINE
- Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection
- (2009) James F. Cummings et al. VACCINE
- Papillomaviruses in the causation of human cancers — a brief historical account
- (2009) Harald zur Hausen VIROLOGY
- Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?
- (2009) David C Montefiori et al. Current Opinion in HIV and AIDS
- Monocyte-Mediated Defense Against Microbial Pathogens
- (2008) Natalya V. Serbina et al. Annual Review of Immunology
- Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities
- (2008) F. Eddahri et al. BLOOD
- An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
- (2008) Katharine Looker BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
- (2008) C. R. Casella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cellular effector mechanisms againstPlasmodiumliver stages
- (2008) Ute Frevert et al. CELLULAR MICROBIOLOGY
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease
- (2008) Vincent G Brichard et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients
- (2008) Jiri Beran EXPERT OPINION ON BIOLOGICAL THERAPY
- Plasmodium falciparummalaria vaccines in development
- (2008) Johan Vekemans et al. Expert Review of Vaccines
- AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention
- (2008) Tino F Schwarz Expert Review of Vaccines
- Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature
- (2008) Tino F. Schwarz et al. GYNECOLOGIC ONCOLOGY
- Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years
- (2008) Tiina Petäjä et al. JOURNAL OF ADOLESCENT HEALTH
- Malaria: progress, perils, and prospects for eradication
- (2008) Brian M. Greenwood et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian human immunodeficiency virus viraemia with protein/DNA combination
- (2008) G. Koopman et al. JOURNAL OF GENERAL VIROLOGY
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
- (2008) Jens Wrammert et al. NATURE
- Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
- (2008) Philip Bejon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
- (2008) Salim Abdulla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
- (2008) Mahamadou A. Thera et al. PLoS One
- Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
- (2008) Meta Roestenberg et al. PLoS One
- Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming
- (2008) D. Atanackovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
- (2008) Kent E. Kester et al. VACCINE
- Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women
- (2008) Troy J. Kemp et al. VACCINE
- Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
- (2008) Thomas Verstraeten et al. VACCINE
- Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen
- (2008) Pascal Mettens et al. VACCINE
- Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
- (2008) Pierre Vandepapelière et al. VACCINE
- Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years
- (2008) Tino F. Schwarz et al. VACCINE
- A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients
- (2007) N.C.T. Kong et al. KIDNEY INTERNATIONAL
- Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial
- (2007) Jahit Sacarlal et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More